Effects of melatonin on orofacial movements in rats

Psychopharmacology

Volumn 161, Issue 4, 2002, Pages 340-347

  Abilio V ^a   Vera, J ^a   Ferreira, L ^a   Duarte, C ^a   Carvalho, R ^a   Grassl, C ^a   Martins, C ^a   Torres Leite, D ^a   Bignotto, M ^a   Tufik, S ^a   Ribeiro, De R ^a   Frussa Filho, R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Dopamine; Melatonin; Orofacial movement; Oxidative stress; Tardive dyskinesia

Indexed keywords

MELATONIN; RESERPINE; SODIUM CHLORIDE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LIGHT DARK CYCLE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TARDIVE DYSKINESIA; AGE; ANIMAL; CORPUS STRIATUM; DYSKINESIA; ILLUMINATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

AGE FACTORS; ANIMAL; CORPUS STRIATUM; DYSKINESIA, DRUG-INDUCED; LIGHTING; LIPID PEROXIDATION; MALE; MELATONIN; RATS; RATS, WISTAR; RESERPINE; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0035987115     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1081-7     Document Type: Article

References (57)

1. Effects of continuous exposure to light on behavioral dopaminergic supersensitivity
2. Neurotoxicity associated with neuroleptic-induced oral dyskinesia in rats
3. Melatonin
4. Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death
5. Movement disorders associated with antipsychotic drugs: Clinical and biological implications
6. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice
7. Oxidative stress-resistant cells are protected against haloperidol toxicity
8. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to motochondria and the glutathione system
9. Effects of age on a new animal model of tardive dyskinesia
10. Antischizophrenic drugs: Chronic treatment elevates dopaminergic receptor in brain
11. The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats
12. Tardive dyskinesia - Pathophysiology
13. 3H]muscimol binding in rat brain
14. Reduced nocturnal melatonin secretion in chronic schizophrenia: Relationship to body weight
15. Neurobiological substrates of tardive dyskinesia: The GABA hypothesis
16. Ascorbic acid and α-tocopherol attenuate methylmalonic acid-induced convulsions
17. Effects of single and long-term administration of sulpiride on open-field and stereotyped behavior of rats
18. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats
19. Pathophysiological mechanisms underlying tardive dyskinesia
20. Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress
21. The pharmacology of tardive dyskinesia
22. Haloperidol increases spreading and nitric oxide production in macrophages from tumor-bearing mice: A possible mechanism for its antitumoral effects
23. Oxygen free radicals and neuropsychiatric illness
24. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia
25. Reduction of myocardial ischemic reperfusion injury by sialylated glycosphingolipids gangliosides
26. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment
27. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats
28. Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: Support for a model of tardive dyskinesia
29. Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia
30. Antihypertensive agents and the drug therapy of hypertension
31. Behavioural models of tardive dyskinesia in rodents: A chronological review
32. Pineal control of aging: Effect of melatonin and pineal grafting on aging mice
33. Effects of buspirone on dopaminergic supersensitivity
34. Effects of buspirone on an animal model of tardive dyskinesia
35. Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats
36. Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: Involvement of peripheral benzodiazepine receptors
37. Aging and the regulation of striatal dopaminergic mechanisms in mice
38. Effects of intranigral substance P and neurokinin A on striatal dopamine release-II. Interactions with bicuculline and naloxone
39. Oxidative process and antioxidative defense mechanisms in the aging brain
40. Functional aspects of the pineal hormone melatonin in combating cell and tissue damage induced by free radicals
41. Oxidative damage in the central nervous system: Protection by melatonin
42. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology)
43. Tardive dyskinesia associated with depression in a bipolar patient: Possible role of melatonin
44. Increased incidence and severity of neuroleptic-induced movement disorder in pinealectomized rats
45. The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome
46. Effect of ganglioside (GM1) on memory in senescent rats
47. Acute reserpine administration elicits long-term spontaneous oral dyskinesia
48. Micro-determination of lipoperoxide in the mouse myocardium by thiobarbituric acid fluorophotometry
49. Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: Involvement of a GABAergic mechanism
50. Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells
51. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy
52. Effects of monosialoganglioside on a new animal model of tardive dyskinesia
53. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia
54. Differential effects of ageing on distinct features of apomorphine stereotypy in the adult rat
55. Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?
56. The association of tardive dyskinesia and pseudoparkinsonism